Race executes global license agreement with City of Hope to access FTO IP
SYDNEY, July 11, 2023 /PRNewswire/ — Race Oncology Limited ("Race") is pleased to announce execution of an exclusive licence agreement ("Agreement"
Stay updated with breaking news from Jianjun Chen. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
SYDNEY, July 11, 2023 /PRNewswire/ — Race Oncology Limited ("Race") is pleased to announce execution of an exclusive licence agreement ("Agreement"
Race Oncology Ltd (ASX:RAC) is trading higher after entering an exclusive licensing agreement to access US cancer research and treatment organisation City...
/PRNewswire/ -- The Leukemia & Lymphoma Society (LLS) recognized and celebrated the outstanding contributions of six LLS-funded scientific investigators for...
RYE BROOK, N.Y., Dec. 14, 2022 /PRNewswire/ -- The Leukemia & Lymphoma Society (LLS) recognized and celebrated the outstanding contributions of si...
Race Oncology Ltd (ASX:RAC) has seen two of its peer-reviewed abstracts published in the prestigious scientific journal Cancer Research with shares trading...